News and events
- By Keyword(s)
There are 74 news items / events (displaying results 11 to 15)
UCLB proof of concept funds help establish UCL drug target and screening facility
Jointly funded by UCLB and the Capital Infrastructure Fund (CIF), the recently established ChemiBank facility in the Wolfson Institute for Biomedical Research at UCL is a fantastic new resource for identifying small molecule ligands for proteins.
Full Story
UCL scientists develop powerful new class of reagents for the modification of proteins
Scientists from the Department of Chemistry at UCL have recently published details of their ground-breaking technology to reversibly conjugate proteins. This is a major technical target, with broad utility in biotherapeutics, drug development, assays, and manufacturing.
Full Story
Domainex, secures funding from Takeda Research Investment..jpg)
The biotechnology company Domainex has secured further financing to develop its Combinatorial Domain Hunting (CDH) technology, and to advance its internal pipeline of oncology targets.
Full Story
UCLB announces new partnership with Kurma Biofund..jpg)
UCLB is delighted to announce a partnership with Kurma Biofund, a recently formed venture capital fund based in Paris and dedicated to innovations in life sciences and healthcare. Kurma recently announced the closing of a first round of financing totalling €50 million.
Full Story
Seeing a Diagnosis: How an eye test could aid Alzheimer’s detection
A simple and inexpensive eye test could aid detection and diagnosis of major neurological diseases such as Alzheimer’s at an earlier stage than is currently possible, according to new research by UCL scientists Professors Francesca Cordeiro & Stephen Moss.
Full Story
« Prev | Page: 1 - 2 - 3 ... | Next »
